안지오텐신 전환효소활성 저해에 의해 항고혈압 효과를 갖는 신품종 감자 구이밸리 추출물

This study was attempted to investigate the anti-hypertensive activity of Solanum tuberosum, cv. Gui valley. Ethanol extract of Gui vally (EGV) increased free radical scarvenge activity up to 91.6% of control at 200 ㎍/㎖. It's anti-oxidant activity is similar to 10 uM of ascorbic acid, well know...

Full description

Saved in:
Bibliographic Details
Published in동의생리병리학회지 Vol. 23; no. 1; pp. 93 - 96
Main Authors 김관현(Kwan Hyun Kim), 김선희(Sun Hee Kim), 이은옥(Eun Ok Lee), 권현정(Hyun Jung Kwon), 최종원(Jong Won Choi), 임학태(Hak Tae Lim), 김성훈(Sung Hoon Kim)
Format Journal Article
LanguageKorean
Published 한의병리학회 01.02.2009
Subjects
Online AccessGet full text
ISSN1738-7698
2288-2529

Cover

More Information
Summary:This study was attempted to investigate the anti-hypertensive activity of Solanum tuberosum, cv. Gui valley. Ethanol extract of Gui vally (EGV) increased free radical scarvenge activity up to 91.6% of control at 200 ㎍/㎖. It's anti-oxidant activity is similar to 10 uM of ascorbic acid, well known as antioxidant. EGV inhibited Angiotensin-I-converting enzyme (ACE) activity in vitro. ACE plays a important role in regulation of blood pressure and ACE inhibitors are important for the treatment of hypertension. Anti-hypertensive activity of EGV in vivo was assessed in lead acetate (LAT)-induced hypertensive rats for 8 weeks. Elevated blood pressure in control group was significantly decreased by EGV at 200 mg/kg. Also, ACE activity in blood was also suppressed by EGV treatment. Taken together, these results suggest that EGV has an anti-hypersive activiy via inhibition of ACE and can be used for the treatment or prevention of hypertension. This study was attempted to investigate the anti-hypertensive activity of Solanum tuberosum, cv. Gui valley. Ethanol extract of Gui vally (EGV) increased free radical scarvenge activity up to 91.6% of control at 200 ㎍/㎖. It's anti-oxidant activity is similar to 10 uM of ascorbic acid, well known as antioxidant. EGV inhibited Angiotensin-I-converting enzyme (ACE) activity in vitro. ACE plays a important role in regulation of blood pressure and ACE inhibitors are important for the treatment of hypertension. Anti-hypertensive activity of EGV in vivo was assessed in lead acetate (LAT)-induced hypertensive rats for 8 weeks. Elevated blood pressure in control group was significantly decreased by EGV at 200 mg/kg. Also, ACE activity in blood was also suppressed by EGV treatment. Taken together, these results suggest that EGV has an anti-hypersive activiy via inhibition of ACE and can be used for the treatment or prevention of hypertension. KCI Citation Count: 0
Bibliography:G704-000534.2009.23.1.018
ISSN:1738-7698
2288-2529